Iterum Therapeutics US Revenue, Growth & Competitor Profile

DBA ITERUM THERAPEUTICS US LIMITED

Company Profile & Annual Report for Iterum Therapeutics US

Access the complete profile.

Iterum Therapeutics US Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	200 S Wacker Dr Ste 2550 Chicago, IL 60606

Note: Revenues for privately held companies are statistical evaluations.


Iterum Therapeutics US's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Iterum Therapeutics US's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Iterum Therapeutics US is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Iterum Therapeutics US Annual Revenue and Growth Rate

Iterum Therapeutics US	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Iterum Therapeutics US's revenues are gauged from an analysis of company filings.

Iterum Therapeutics US's Income Statement (based on Industry Averages)

Iterum Therapeutics US P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Iterum Therapeutics US's Largest Competitors

A competitive analysis shows these companies are in the same general field as Iterum Therapeutics US, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Iterum Therapeutics US. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FERMI RESEARCH ALLIANCE	Chicago, IL	100
PHARMACANN	Chicago, IL	33
XERIS PHARMACEUTICALS	Chicago, IL	20
HEALTH UTILITY NETWORK	Chicago, IL	13
CHAPIN HALL CENTER FOR CHILDREN	Chicago, IL	9
IIT RESEARCH INSTITUTE	Chicago, IL	6

Other Companies at 200 S Wacker Dr, Chicago IL

Company	Headquarters	Revenue ($ MM)
PRESENCE HEALTH	Chicago, IL	100
B. C. ZIEGLER	Chicago, IL	11
CLARO HEALTHCARE	Chicago, IL	6
AMERICAN THEOLOGICAL LIBRARY ASSOCIATION	Chicago, IL	1
OUT FOR DELIVERY DOMESTIC & LOGISTIC SERVICES	Chicago, IL	0

Future Competition: Iterum Therapeutics US's Fastest Growing Competitors

These companies are in the same general field as Iterum Therapeutics US and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)